Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration
2008

Rapid Cognitive Improvement in Alzheimer's Disease with Etanercept

Sample size: 1 publication Evidence: low

Author Information

Author(s): Edward L Tobinick, Hyman Gross

Primary Institution: Department of Medicine, Institute for Neurological Research, Los Angeles, USA

Hypothesis

The administration of perispinal etanercept will lead to rapid cognitive improvement in patients with Alzheimer's disease.

Conclusion

The study found that perispinal etanercept administration resulted in rapid cognitive improvement in a patient with late-onset Alzheimer's disease.

Supporting Evidence

  • Etanercept is known to block the effects of excess TNF-alpha, which is implicated in Alzheimer's disease.
  • The patient showed marked cognitive improvement within minutes of treatment.
  • Family members confirmed the patient's cognitive improvements after treatment.

Takeaway

A patient with Alzheimer's disease got much better at thinking and remembering just minutes after getting a special treatment called etanercept.

Methodology

The patient received a single dose of 25 mg of etanercept via perispinal administration, followed by cognitive assessments before and after treatment.

Potential Biases

All participants, including the examining physicians, were aware of the treatment modality, which could bias the results.

Limitations

The study is based on a single case report, and the authors acknowledge potential bias due to the lack of a control group.

Participant Demographics

The patient was an 81-year-old male physician with late-onset Alzheimer's disease.

Digital Object Identifier (DOI)

10.1186/1742-2094-5-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication